Willfulness Claims Stricken In 4 ADHD Drug Suits
A federal judge has dismissed claims of willful infringement from four separate actions brought by Celgene Corp. and Novartis Pharmaceuticals Corp. to stop several rival pharmaceutical companies from marketing and selling...To view the full article, register now.
Already a subscriber? Click here to view full article